Cargando…
The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
BACKGROUND: Much progress has been made in mapping genetic abnormalities linked to amyotrophic lateral sclerosis (ALS), but the majority of cases still present with no known underlying cause. Furthermore, even in families with a shared genetic abnormality there is significant phenotypic variability,...
Autores principales: | Boddy, Sarah L., Giovannelli, Ilaria, Sassani, Matilde, Cooper-Knock, Johnathan, Snyder, Michael P., Segal, Eran, Elinav, Eran, Barker, Lynne A., Shaw, Pamela J., McDermott, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816375/ https://www.ncbi.nlm.nih.gov/pubmed/33468103 http://dx.doi.org/10.1186/s12916-020-01885-3 |
Ejemplares similares
-
The Gut Microbiome and Individual-Specific Responses to Diet
por: Leshem, Avner, et al.
Publicado: (2020) -
Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence
por: Chapman, Laura, et al.
Publicado: (2023) -
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
por: Cooper-Knock, Johnathan, et al.
Publicado: (2015) -
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
por: Boddy, Sarah, et al.
Publicado: (2022) -
Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis
por: Beer, Alexander M., et al.
Publicado: (2016)